Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1994;3(6):419–424. doi: 10.1155/S0962935194000591

Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)

M Jäpel 1, H Lötzerich 1,✉, K Rogalla 2
PMCID: PMC2365582  PMID: 18475590

Abstract

In addition to the spectrum of biological action already known to be exhibited by acetylsalicylic acid (ASA) as an analgesic, anti-inflammatory and platelet aggregation inhibitor, there is growing evidence of a stimulatory effect on the immune system. ASA has been found to increase the production ofcytokines and to increase the activity of various leukocytes. The action of ASA on the activity of mouse peritoneal macrophages was therefore investigated in the present study. Therapeutically effective concentrations of ASA, which are known to decrease levels of prostaglandins, had neither a stimulating nor an inhibiting influence on antibody-dependent cellular cytotoxicity (ADCC) or on the binding capacity of macrophages with regard to SW 948 tumour cells. Likewise ASA had little or no adverse effect on the capacity of the macrophages for stimulation by interferon-gamma (IFN-gamma) and interleukin-4 (IL-4). Taken together, the immunostimulant effect of ASA shown in the literature as an increased production of interleukin-2 (IL-2) and IFN, could not be confirmed on the basis of the macrophage cytotoxiclty.

Full Text

The Full Text of this article is available as a PDF (596.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Hall T., Steplewski Z., Koprowski H. Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3506–3510. doi: 10.1073/pnas.81.11.3506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams D. O. Molecular interactions in macrophage activation. Immunol Today. 1989 Feb;10(2):33–35. doi: 10.1016/0167-5699(89)90298-3. [DOI] [PubMed] [Google Scholar]
  3. Brunda M. J., Herberman R. B., Holden H. T. Inhibition of murine natural killer cell activity by prostaglandins. J Immunol. 1980 Jun;124(6):2682–2687. [PubMed] [Google Scholar]
  4. Cesario T. C., Yousefi S., Carandang G. The regulation of interferon production by aspirin, other inhibitors of the cyclooxygenase pathway and agents influencing calcium channel flux. Bull N Y Acad Med. 1989 Jan;65(1):26–35. [PMC free article] [PubMed] [Google Scholar]
  5. Chouaib S., Chatenoud L., Klatzmann D., Fradelizi D. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol. 1984 Apr;132(4):1851–1857. [PubMed] [Google Scholar]
  6. Creagan E. T., Twito D. I., Johansson S. L., Schaid D. J., Johnson P. S., Flaum M. A., Buroker T. R., Geeraerts L. H., Veeder M. H., Gesme D. H., Jr A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma. J Clin Oncol. 1991 Dec;9(12):2104–2109. doi: 10.1200/JCO.1991.9.12.2104. [DOI] [PubMed] [Google Scholar]
  7. Dinarello C. A. Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities. Bull N Y Acad Med. 1989 Jan;65(1):80–92. [PMC free article] [PubMed] [Google Scholar]
  8. Droller M. J., Schneider M. U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells. Cell Immunol. 1978 Aug;39(1):165–177. doi: 10.1016/0008-8749(78)90091-6. [DOI] [PubMed] [Google Scholar]
  9. Fan S., Fehr H. G., Adams D. Activation of macrophages for ADCC in vitro: effects of IL-4, TNF, interferons-alpha/beta, interferon-gamma, and GM-CSF. Cell Immunol. 1991 Jun;135(1):78–87. doi: 10.1016/0008-8749(91)90255-a. [DOI] [PubMed] [Google Scholar]
  10. Field W. E., 2nd, Ferguson F. G., Reddanna P., Reddy C. C. The effect of selected arachidonic acid metabolites on natural killer cell activity. Prostaglandins. 1988 Oct;36(4):411–419. doi: 10.1016/0090-6980(88)90039-1. [DOI] [PubMed] [Google Scholar]
  11. Garovoy M. R., Strom T. B., Kaliner M., Carpenter C. B. Antibody-dependent lymphocyte mediated cytotoxicity mechanism and modulation by cyclic nucleotides. Cell Immunol. 1975 Dec;20(2):197–204. doi: 10.1016/0008-8749(75)90097-0. [DOI] [PubMed] [Google Scholar]
  12. Goodwin J. S., Ceuppens J. Regulation of the immune response by prostaglandins. J Clin Immunol. 1983 Oct;3(4):295–315. doi: 10.1007/BF00915791. [DOI] [PubMed] [Google Scholar]
  13. Goodwin J. S., Webb D. R. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 Jan;15(1):106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  14. Hial V., Horakova Z., Shaff F. E., Beaven M. A. Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. Eur J Pharmacol. 1976 Jun;37(2):367–376. doi: 10.1016/0014-2999(76)90044-3. [DOI] [PubMed] [Google Scholar]
  15. Hockertz S., Schettler T., Rogalla K. Effect of acetylsalicylic acid, ascorbate and ibuprofen on the macrophage system. Arzneimittelforschung. 1992 Aug;42(8):1062–1068. [PubMed] [Google Scholar]
  16. Hsia J., Sarin N., Oliver J. H., Goldstein A. L. Aspirin and thymosin increase interleukin-2 and interferon-gamma production by human peripheral blood lymphocytes. Immunopharmacology. 1989 May-Jun;17(3):167–173. doi: 10.1016/0162-3109(89)90045-3. [DOI] [PubMed] [Google Scholar]
  17. Hsia J., Simon G. L., Higgins N., Goldstein A. L., Hayden F. G. Immune modulation by aspirin during experimental rhinovirus colds. Bull N Y Acad Med. 1989 Jan;65(1):45–56. [PMC free article] [PubMed] [Google Scholar]
  18. Johnson W. J., Adams D. O. Assays detecting the antibody-dependent and independent binding and cytolysis of tumor cells by murine macrophages. Methods Enzymol. 1986;132:555–568. doi: 10.1016/s0076-6879(86)32041-x. [DOI] [PubMed] [Google Scholar]
  19. Johnson W. J., Bolognesi D. P., Adams D. O. Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis. Cell Immunol. 1984 Jan;83(1):170–180. doi: 10.1016/0008-8749(84)90236-3. [DOI] [PubMed] [Google Scholar]
  20. Juan H. Kürzlich entdeckte Wirkungsmechanismen der nichtsteroidalen Antirheumatika: mögliche, nicht nur symptomatische therapeutische Effekte. Wien Klin Wochenschr. 1983 Dec 23;95(24):865–869. [PubMed] [Google Scholar]
  21. Kunkel S. L., Chensue S. W., Phan S. H. Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol. 1986 Jan;136(1):186–192. [PubMed] [Google Scholar]
  22. Leibovitz A., Stinson J. C., McCombs W. B., 3rd, McCoy C. E., Mazur K. C., Mabry N. D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976 Dec;36(12):4562–4569. [PubMed] [Google Scholar]
  23. Lupulescu A. Enhancement of carcinogenesis by prostaglandins. Nature. 1978 Apr 13;272(5654):634–636. doi: 10.1038/272634a0. [DOI] [PubMed] [Google Scholar]
  24. Lynch N. R., Castes M., Astoin M., Salomon J. C. Mechanism of inhibition of tumour growth by aspirin and indomethacin. Br J Cancer. 1978 Oct;38(4):503–512. doi: 10.1038/bjc.1978.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nacy C. A., Meltzer M. S. T-cell-mediated activation of macrophages. Curr Opin Immunol. 1991 Jun;3(3):330–335. doi: 10.1016/0952-7915(91)90033-w. [DOI] [PubMed] [Google Scholar]
  26. Okonogi K., Gettys T. W., Uhing R. J., Tarry W. C., Adams D. O., Prpic V. Inhibition of prostaglandin E2-stimulated cAMP accumulation by lipopolysaccharide in murine peritoneal macrophages. J Biol Chem. 1991 Jun 5;266(16):10305–10312. [PubMed] [Google Scholar]
  27. Plescia O. J., Smith A. H., Grinwich K. Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci U S A. 1975 May;72(5):1848–1851. doi: 10.1073/pnas.72.5.1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rappaport R. S., Dodge G. R. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med. 1982 Mar 1;155(3):943–948. doi: 10.1084/jem.155.3.943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Roth G. J., Siok C. J. Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin. J Biol Chem. 1978 Jun 10;253(11):3782–3784. [PubMed] [Google Scholar]
  30. Rumore M. M., Aron S. M., Hiross E. J. A review of mechanism of action of aspirin and its potential as an immunomodulating agent. Med Hypotheses. 1987 Apr;22(4):387–400. doi: 10.1016/0306-9877(87)90034-x. [DOI] [PubMed] [Google Scholar]
  31. Schenkelaars E. J., Bonta I. L. Cyclooxygenase inhibitors promote the leukotriene C4 induced release of beta-glucuronidase from rat peritoneal macrophages: prostaglandin E2 suppresses. Int J Immunopharmacol. 1986;8(3):305–311. doi: 10.1016/0192-0561(86)90112-8. [DOI] [PubMed] [Google Scholar]
  32. Somers S. D., Erickson K. L. Regulation of murine macrophage function by IL-4. I. Activation of macrophages by a T-T cell hybridoma is due to IL-4. Cell Immunol. 1989 Aug;122(1):178–187. doi: 10.1016/0008-8749(89)90158-5. [DOI] [PubMed] [Google Scholar]
  33. Thun M. J., Namboodiri M. M., Heath C. W., Jr Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593–1596. doi: 10.1056/NEJM199112053252301. [DOI] [PubMed] [Google Scholar]
  34. Trofatter K. F., Jr, Daniels C. A. Interaction of human cells with prostaglandins and cyclic AMP modulators. I. Effects on complement-mediated lysis and antibody-dependent cell-mediated cytolysis of herpes simplex virus-infected human fibroblasts. J Immunol. 1979 Apr;122(4):1363–1370. [PubMed] [Google Scholar]
  35. Valdéz J. C., Perdigón G. Piroxicam, indomethacin and aspirin action on a murine fibrosarcoma. Effects on tumour-associated and peritoneal macrophages. Clin Exp Immunol. 1991 Nov;86(2):315–321. doi: 10.1111/j.1365-2249.1991.tb05816.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Voth R., Chmielarczyk W., Storch E., Kirchner H. Induction of natural killer cell activity in mice by injection of indomethacin. Nat Immun Cell Growth Regul. 1986;5(6):317–324. [PubMed] [Google Scholar]
  37. Waymack J. P., Yurt R. W. Effect of prostaglandin E on immune function in multiple animal models. Arch Surg. 1988 Nov;123(11):1429–1432. doi: 10.1001/archsurg.1988.01400350143023. [DOI] [PubMed] [Google Scholar]
  38. Wersäll P., Masucci G., Mellstedt H. Interleukin-4 augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother. 1991;33(1):45–49. doi: 10.1007/BF01742527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Young M. R., Newby M. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice. J Natl Cancer Inst. 1986 Dec;77(6):1255–1260. [PubMed] [Google Scholar]
  40. Young M. R., Newby M. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages. Cancer Res. 1986 Jan;46(1):160–164. [PubMed] [Google Scholar]
  41. Young M. R., Wheeler E., Newby M. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J Natl Cancer Inst. 1986 Apr;76(4):745–750. doi: 10.1093/jnci/76.4.745. [DOI] [PubMed] [Google Scholar]
  42. Yousefi S., Chiu J., Carandang G., Archibeque E. G., Vaziri N., Cesario T. C. Effect of acetyl salicylic acid on production and action of leukocyte-derived interferons. Antimicrob Agents Chemother. 1987 Jan;31(1):114–116. doi: 10.1128/aac.31.1.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Zatz M. M., Skotnicki A., Bailey J. M., Oliver J. H., Goldstein A. L. Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production. Immunopharmacology. 1985 Jun;9(3):189–198. doi: 10.1016/0162-3109(85)90015-3. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES